Long-term health risk of primary hyperparathyroidism: The effect of surgery

Annals of Medicine

Volumn 28, Issue 2, 1996, Pages 95-100

  Sivula, Arto ^a,b   Pelkonen, Risto ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE   (Finland)

Author keywords

Hypercalcaemia; Indications for surgery; Primary hyperparathyroidism; Risk of death

Indexed keywords

AGED; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DEATH; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HYPERCALCEMIA; KIDNEY DISEASE; MENTAL DISEASE; MORBIDITY; MORTALITY; NEUROMUSCULAR DISEASE; OSTEITIS FIBROSA; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; THYROID SURGERY;

EID: 0029965942     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899609092932     Document Type: Review

References (41)

1. Christensson T, Hellström K, Wengle B, Alveryd A, Wikland B. Prevalence of hypercalcemia in a health screening in Stockholm. Acta Med Scand 1976; 200: 131-7.
2. Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N Engl J Med 1980; 302: 189-93.
3. Palmér M, Jakobsson S, Åkerström G, Ljunghall S. Prevalence of hypercalcemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Invest 1988; 18: 39-46.
4. Ljunghall S, Hellman P, Rastad J, Åkerström G. Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture. World J Surg 1991; 15: 681-7.
5. Ronni-Sivula H. Causes of death in patients previously operated on for primary hyperparathyroidism. Ann Chir Gynaecol 1985; 74: 13-8.
6. Palmér M, Adami H-O, Bergström R, Åkerström G, Ljunghall S. Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 1987; 102: 1-7.
7. Palmér M, Adami H-O, Bergström R, Jakobsson S, Åkerström G, Ljunghall S. Survival and renal function in untreated hypercalcemia. Population-based cohort study with 14 years of foilow-up. Lancet 1987; i: 59-62.
8. Hedbäck G, Tisell L-E, Bengtsson B-Å, Hedman I, Odén A. Premature death in patients operated on for primary hyperparathyroidism. World J Surg 1990; 14: 829-36.
9. Marx SJ. Genetic defects in primary hyperparathyroidism. N Engl J Med 1988; 318: 699-701.
10. Posen S. Asymptomatic primary hyperparathyroidism: the case for conservative management. Aust N Z J Med 1992; 22: 161-3.
11. Silverberg SJ, Shane E, de la Cruz L, et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 1989; 4: 283-91.
12. Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM. Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 1988; 67: 1294-8.
13. Wilson RJ, Rao DS, Ellis B, Kleerekoper M, Parfitt AM. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 1988; 109: 959-62.
14. Heath DA. Primary hyperparathyroidism. Clinical presentation and factors influencing clinical management. Endocrinol Metab Clin North Am 1989; 18: 631-46.
15. Ronni-Sivula H, Sivula A. Long-term effect of surgical treatment on the symptoms of primary hyperparathyroidism. Ann Clin Res 1985; 17: 141-7.
16. Lafferty FW, Hubay CA. Primary hyperparathyroidism. A review of the long-term surgical and nonsurgical morbidities as a basis for a rational approach to treatment. Arch Intern Med 1989; 149: 789-96.
17. Prager R, Schernthaner G, Niederle B, Roka R. Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery. Calcif Tissue Int 1990; 46: 1-4.
18. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 1993; 95: 197-202.
19. Patten BM, Bilezikian JP, Mallette LE, Prince A, Engel WK, Aurbach GD. Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med 1974; 80: 182-93.
20. Joborn C, Joborn H, Rastad J, Åkerström G, Ljunghall S. Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery. Br J Surg 1988; 75: 77-80.
21. Joborn C, Hetta J, Lind L, Rastad J, Åkerström G, Ljunghall S. Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia. Surgery 1989; 105: 72-8.
22. Clark OH, Wilkes W, Siperstein AE, Duh QY. Diagnosis and management of asymptomatic hyperparathyroidism: safety, efficacy, and deficiences in our knowledge. J Bone Miner Res 1991; 6 (Suppl 2): S135-42.
23. Heath DA, Heath EM. Conservative management of primary hyperparathyroidism. J Bone Miner Res 1991; 6 (Suppl 2): S117-20.
24. Christensson T, Hellström K, Wengle B. Clinical and laboratory findings in subjects with hypercalcemia. A study including cases with primary hyperparathyroidism detected in a health screening. Acta Med Scand 1976; 200: 355-60.
25. Harrison BJ, Wheeler MH. Asymptomatic primary hyperparathyroidism. World J Surg 1991; 15: 724-9.
26. Brown EM, Pollak M, Seidman CE, et al. Calcium-ion-sensing cell-surface receptors. N Engl J Med 1995; 333: 234-9.
27. Russell CF, Edis AJ. Surgery for primary hyperparathyroidism. Experience with 500 consecutive cases and evaluation of the role of surgery in the asymptomatic patient. Br J Surg 1982; 69: 244-7.
28. Kjellman M, Sandelin K, Farnebo L-O. Primary hyperparathyroidism. Low surgical morbidity supports liberal attitude to operation. Arch Surg 1994; 129: 237-40.
29. Kairaluoma MV, Mäkäräinen H, Kellosalo J, Haukipuro K, Pirttiaho H, Kairaluoma MI. Preoperative ultrasound in patients undergoing initial neck exploration for primary hyperparathyroidism. Ann Chir Gynaecol 1993; 82: 171-6.
30. Sivula A, Ronni-Sivula H. Observations on 334 patients operated on for primary hyperparathyroidism. Ann Chir Gynaecol 1985; 74: 66-73.
31. Alhava EM, Karjalainen P, Pääkkönen P. Bone mineral density and surgical treatment of primary hyperparathyroidism. Acta Chir Scand 1988; 154: 345-7.
32. Mautalen C, Reyes HR, Ghiringhelli G, Fromm G. Cortical bone mineral content in primary hyperparathyroidism. Changes after parathyroidectomy. Acta Endocrinol 1936; 111: 494-7.
33. Wells SA Jr. Surgical therapy of patients with primary hyperparathyroidism: long-term benefits. J Bone Miner Res 1991; 6 (Suppl 2): S143-9.
34. Heath DA, Wright AD, Barnes AD, Oates GD, Dorricott NJ. Surgical treatment of primary hyperparathyroidism in the elderly. BMJ 1980; 280: 1406-8.
35. Joborn C, Hetta J, Rastad J, Agren H, Åkerström G, Ljunghall S. Psychiatric symptoms and cerebrospinal fluid monoamine metabolites in primary hyperparathyroidism. Biol Psychiatry 1988; 23: 149-58.
36. Sivula A, Ronni-Sivula H. Natural history of treated primary hyperparathyroidism. Surg Clin North Am 1987; 67: 329-41.
37. Hedbäck G, Odén A, Tisell L-E. The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 1991; 15: 399-407.
38. Hedbäck G, Odén A. Clinical evaluation of total serum calcium in primary hyperparathyroidism and the risk of death after surgery. Eur J Clin Invest 1995; 25: 48-52.
39. Hedbäck G, Odén A, Tisell L-E. Parathyroid adenoma weight and the risk of death after treatment for primary hyperparathyroidism. Surgery 1995; 117: 134-9.
40. Bilezikian JP. Management of hypercalcemia. J Clin Endocrinol Metab 1993; 77: 1445-9.
41. NIH Conference. Diagnosis and management of asymptomatic primary hyperparathyroidism. Consensus development conference statement. Ann Intern Med 1991; 114: 593-7.